Covid-19, prise en charge, pistes thérapeutiques et vaccinales - 21/10/20
COVID-19, management, therapeutic and vaccine approaches
Riassunto |
Alors qu’au début de l’année 2020, l’épidémie de Covid-19 se propageait à toute vitesse, de très nombreuses équipes scientifiques se sont mises au travail à travers le monde. La prise en charge des infections au severe acute respiratory syndrome coronavirus 2 repose sur des traitements non spécifiques (symptomatiques) ou spécifiques (curatifs) expérimentaux. Le vaccin sera la clé d’une immunisation sur le long terme.
Il testo completo di questo articolo è disponibile in PDF.COVID-19, management, therapeutic and vaccine approaches |
While at the beginning of 2020, the COVID-19 epidemic was spreading at tremendous speed, many scientific teams set to work around the world. The management of severe acute respiratory syndrome coronavirus 2 infections is based on experimental non-specific (symptomatic) or specific (curative) treatments. The vaccine will be the key to long-term immunization.
Il testo completo di questo articolo è disponibile in PDF.Mots clés : Covid-19, pharmacologie, Sars-CoV-2, vaccin
Keywords : COVID-19, pharmacology, Sars-CoV-2, vaccine
Mappa
Vol 59 - N° 599
P. 27-33 - Ottobre 2020 Ritorno al numeroBenvenuto su EM|consulte, il riferimento dei professionisti della salute.